Disse vurderinger af de kliniske tegn viser, at svært erytem (31%), kraftige erosioner (13%) og kraftig skorpedannelse (19%) var meget almindeligt i disse forsøg med Imiquimod- creme påført 5 gange om ugen.
These protocol mandated clinical sign assessments indicate that severe erythema (31%) severe erosions (13%) and severe scabbing and crusting (19%) were very common in these trials with imiquimod cream applied 5 times weekly.